Oncologist Dr. David Minor to Discuss New Options for Kidney Cancer Patients
SAN FRANCISCO, Calif. -- California Kidney Cancer Foundation Executive Director, Dr. David Minor will present a review of treatments for metastatic kidney cancer as presented at the most recent American Society of Clinical Oncology Conference. The presentation will be from 3 to 5 PM on September 15, 2007 at California Pacific Medical Center.
OCuSOFT, Inc. Names Edward J. Holland, M.D. to Medical Scientific Advisory Board
RICHMOND, Texas -- CYNACON / OCuSOFT (OCuSOFT, Inc.), a company specializing in ophthalmic research, development and supply to ophthalmologists and optometrists, is pleased to announce the appointment of Edward J. Holland, M.D. to its Medical Scientific Advisory Board.
Baker County Medical Services Posts Its Charges on Their Website
MACCLENNY, Fla. -- Baker County Medical Services which operates Ed Fraser Memorial Hospital in Macclenny, Florida announced today that they have posted all of their hospital charges contained in their Charge Master on their website.
Ophthalmic Research and Development Company Launches Adjunctive Eyelid Therapy and Hygiene Product

OCuSOFT, Inc. Names Lawrence A. Yannuzzi, M.D. to Medical Scientific Advisory Board
RICHMOND, Texas -- CYNACON / OCuSOFT (OCuSOFT, Inc.), a company specializing in ophthalmic research, development and supply to ophthalmologists and optometrists, today announced the appointment of Lawrence A. Yannuzzi, M.D. to its Medical Scientific Advisory Board.
iPhone Browses Diagnostic Heart Images with HeartIT Medical Imaging Solution

Fertility and Hormonal Health Expert Dr. Robert Greene to Lead Sacramento Reproductive Practice
SACRAMENTO, Calif. -- The Sher Institute for Reproductive Medicine(SM) - Sacramento (SIRM-Sacramento) has announced that Dr. Robert Greene will join as full-time medical director, operating out of the Sacramento headquarters as well as the Pleasanton and newly-established Redding satellite offices.
Biotechnology Company Takes Aim at Pancreatic Cancer With an Advanced Phase I/II Clinical Trial Using Rexin-G™
SAN MARINO, Calif. -- Epeius Biotechnologies Corporation announced today that an advanced Phase I/II clinical trial using intravenous Rexin-G(TM) for pancreatic cancer that is refractory to standard chemotherapy will open in the summer of 2007 in Los Angeles, California. Rexin-G is the world's first tumor-targeted injectable gene delivery system that is designed to seek out and destroy both primary tumors and metastatic cancers that have spread throughout the body.
Previser Corp. and National Children's Oral Health Foundation Launch Initiative to Reduce Oral Disease Among Disadvantaged Populations
CHARLOTTE, N.C. -- The National Children's Oral Health Foundation (NCOHF) and PreViser Corporation today announced a joint initiative to collaborate in an effort to improve the oral health of low income children nationwide. The NCOHF, whose non-profit mission is to eliminate oral disease, and promote overall health and well-being for economically disadvantaged children.
Sher Institute Infertility Practice In Monmouth County, NJ Announces New Medical Director and Expanded Operations
SHREWSBURY, N.J. -- The Sher Institute for Reproductive Medicine(SM)-New Jersey (SIRM(TM)-NJ), part of one of the largest and fastest growing infertility networks in the United States, has announced that Douglas Rabin, MD, has joined SIRM's Monmouth/Ocean County office (located in Shrewsbury) as its Medical Director.